CSL Ltd Sustainability Reports
CSL Limited is a global specialty biotechnology company that researches, develops, manufactures, and markets biopharmaceutical products to treat and prevent serious human medical conditions. The company's core operations include blood plasma derivatives, vaccines, iron deficiency therapies, and nephrology medicines.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 529900ECSECK5ZDQTE14
FIGI: BBG001S7YNK1
36 reports from 2008 to 2026